维普中文期刊产品整合服务
19篇 您的检索式:作者名="Mutnick A"
    题名 作者 年代 出处 被引量
1Antimicrobial activity of LB10827,a new orally administered cephalosporin,tested against Haemophilus influenzae,Moraxella catarrhalis,and Streptococcus pneumoniae显示文摘Deshpande L M Beach M L Mutnick A H 2003Clin Microbiol Infect2003,9,8:1
2Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway显示文摘Yamboliev I A Hedges J C Mutnick J L 2000Am J Physiol Heart Circ Physiol2000,278,6:1
3Geographic variations in garenoxacin(BMS284756)activity tested against pathogens associated with skin and soft tissue infections:report from the SENTRY Antimicrobial Surveillance Program(2000)显示文摘Kirby J T Mutnick A H Jones R N 2002Diagn Microbiol Infect Dis2002,439,4:1
4Using multiple pharmacoeconomic methods to conduct a cost-effectiveness analysis of histamine H2- receptor antagonists 显示文摘McCoy S Blayney-Chandramouli J Mutnick A 1998Am J Health-Syst Pharm1998,55,4:1
5PBL and beyond: trends in collaborative learning 显示文摘Pluta WJ Richards BF Mutnick A 2013Teach Learn Med2013,25,1:1
6Antimicrobialusage and resistatace trend relationships from the MYSTIC Programme in North America (1999-2001)显示文摘Mutnick A H Rhomberg P R Sader H S 2004J Antimicrob Chemother2004,53,2:1
7Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections:report from the SENTRY Antimicrobial Surveillance Program(United States and Canada,2000)显示文摘Rennie R P Jones R N Mutnick A H 2003Diagn Microbiol Infect Dis2003,45,4:1
8Pharmacist- versus physician-obtainedmedication histories 显示文摘Reeder TA Mutnick A 2008Am J Health Syst Pharm2008,65,9:1
9Safety concerns associated with the use of immediate-release sugblingual nifedipinea显示文摘 2000P&T News2000,9,:1
10Antimicrobial usage and resistatace trend relationships from the MYSTIC Programme in North America (1999- 2001)显示文摘Mutnick A H Rhomberg P R Sader H S et a1 2004J Antimicrob Chemother2004,53,2:1
11Safety concerns associated with the use of immediate-release sugblingual nifedipinez显示文摘Barbara A Mutnick R 2000P & T News2000,9,:1
12Using multiple pharmacoeconomic methods to condut a cost - effectiveness analysis of histamine H2 - receptor antagonists 显示文摘McCoy S Blayney - Chandramouli J Mutnick A 1998Am J Health Syst pharm1998,55,4:1
13Linezolid resistancesince 2001: Sentry antimicrobial surveillance program显示文摘Mutnick A H Enne V Jones R N 2003Ann Pharmacother2003,37,6:1
14Using multiple pharmacoeconomic methods to condut a cost-effectiveness analysis of histamine H2-receptor antagonists显示文摘 Blayney-Chandramouli J Mutnick A 1998Am J Health Syst Pharm1998,55,4:1
15Pharmacist-versus physician-obtained medication histories显示文摘Reeder TA Mutnick A 0,,09:1
16Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway显示文摘Yamboliev I A Hedges J C Mutnick J L 2000Am J Physiol Heart Circ Physiol2000,278,6:1
17Primary brain in adults and the use of common household appliances: a case-control study 显示文摘Mutnick A Muscat J E 1997Rev Environ Health1997,12,2:1
18Using multiple pharmacoeconomic methods to conduct a cost-effectiveness analysis of histamine H2-reeeptor antagonists显示文摘McCoy S Blayney-Chandramouli J Mutnick A 1998Am J Health Syst Pharm1998,15,55:1
19Ventricular fibrillation and anoxic encephalopathy secondary to astemizole overdose 显示文摘Burke T G Mutnick A H 1993Ann Pharmacother1993,27,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费